Literature DB >> 10969305

Diagnosing sensory abnormalities with either normal values or values from contralateral skin: comparison of two approaches in complex regional pain syndrome I.

M A Kemler1, H J Schouten, R H Gracely.   

Abstract

BACKGROUND: To diagnose sensory abnormalities, patient values can be compared with values of the general population (absolute approach) or to values measured at contralateral homologous skin (relative approach). The current study gives normal values for both approaches and compares the advantages of each method by applying the technique to patients with complex regional pain syndrome type I (CRPS I).
METHODS: In 50 healthy control subjects, sensory and pain thresholds were measured for pressure, warmth, and cold on both wrists and both feet. In 53 patients with unilateral CRPS I (33 hand, 20 foot), the same assessments were conducted twice, at an interval of 1 month.
RESULTS: In control subjects, contralateral homologous sides have approximately the same sensitivity, supporting the validity of the relative approach in patients. Hypoesthesia and allodynia can be diagnosed by either the absolute or relative approach, whereas hyperesthesia and hypoalgesia can only be identified with the relative approach. The two approaches obtain different results in 20% of cases. Age, gender, and subject criteria may influence the absolute but not the relative approach. Both approaches are comparable with regard to reproducibility. Frequency distributions of sensory abnormalities in chronic CRPS I are presented. The most frequent diagnoses were cold allodynia and mechanical hypoesthesia and allodynia.
CONCLUSIONS: To divide sensory characteristics into a binary classification of "normal" and "abnormal," the relative approach is the best choice, with the exception of cases in which the contralateral homologous side is absent or affected by disease. The authors recommend the relative approach for both research and clinical purposes.

Entities:  

Mesh:

Year:  2000        PMID: 10969305     DOI: 10.1097/00000542-200009000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

Review 1.  Complex [corrected] regional pain syndrome: what specialized rehabilitation services do patients require?

Authors:  I Elias Veizi; Thomas C Chelimsky; Jeffrey W Janata
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 2.  Perspectives on next steps in classification of oro-facial pain - Part 3: biomarkers of chronic oro-facial pain - from research to clinic.

Authors:  W Ceusters; C Nasri-Heir; D Alnaas; B E Cairns; A Michelotti; R Ohrbach
Journal:  J Oral Rehabil       Date:  2015-07-22       Impact factor: 3.837

3.  Thermal hypesthesia in patients with complex regional pain syndrome related dystonia.

Authors:  Alexander G Munts; Monique A van Rijn; Erica J Geraedts; Jacobus J van Hilten; J Gert van Dijk; Johan Marinus
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 4.  Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain.

Authors:  Alaa Abd-Elsayed; Markus Jackson; Steven L Gu; Kenneth Fiala; Jianguo Gu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

5.  Can within-subject comparisons of thermal thresholds be used for diagnostic purposes?

Authors:  Ø Dunker; M U Lie; K B Nilsen
Journal:  Clin Neurophysiol Pract       Date:  2021-02-04

6.  Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin model.

Authors:  Catherine E Ferland; Chantal Villemure; Pierre-Emmanuel Michon; Wiebke Gandhi; My-Linh Ma; Florian Chouchou; Alexandre J Parent; M Catherine Bushnell; Gilles Lavigne; Pierre Rainville; Mark A Ware; Philip L Jackson; Petra Schweinhardt; Serge Marchand
Journal:  Can J Pain       Date:  2018-10-23

7.  Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].

Authors:  Anton C van de Vusse; Suzanne G M Stomp-van den Berg; Alfons H F Kessels; Wim E J Weber
Journal:  BMC Neurol       Date:  2004-09-29       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.